Oxygen therapy may boost stem cells – new study investigates
NCT ID NCT06748586
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will measure how hyperbaric oxygen therapy (HBOT) changes the number of stem cells in the blood of 60 adults aged 20 to 80 who are already scheduled to receive HBOT for other medical reasons. Researchers will take blood samples at different times during treatment to count specific stem cell markers. The goal is to understand the body's response to HBOT, not to treat any disease directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRCULATING HEMATOPOIETIC STEM CELLS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh)
RECRUITINGZrifin, 70300, Israel